45 related articles for article (PubMed ID: 26220468)
1. Small Molecule NF-κB Inhibitors as Immune Potentiators for Enhancement of Vaccine Adjuvants.
Moser BA; Escalante-Buendia Y; Steinhardt RC; Rosenberger MG; Cassaidy BJ; Naorem N; Chon AC; Nguyen MH; Tran NT; Esser-Kahn AP
Front Immunol; 2020; 11():511513. PubMed ID: 33072085
[TBL] [Abstract][Full Text] [Related]
2. Delivery Strategies, Structural Modification, and Pharmacological Mechanisms of Honokiol: A Comprehensive Review.
Pan C; Li Q; Xiong S; Yang Y; Yang Y; Huang C; Wang ZP
Chem Biodivers; 2024 Jun; 21(6):e202302032. PubMed ID: 38308434
[TBL] [Abstract][Full Text] [Related]
3. Antihyperalgesic Properties of Honokiol in Inflammatory Pain Models by Targeting of NF-κB and Nrf2 Signaling.
Khalid S; Ullah MZ; Khan AU; Afridi R; Rasheed H; Khan A; Ali H; Kim YS; Khan S
Front Pharmacol; 2018; 9():140. PubMed ID: 29615898
[TBL] [Abstract][Full Text] [Related]
4. Honokiol, an active compound of
Chou PY; Chang WC; Liu FC; Lan SJ; Sheu MJ; Chen JS
Food Sci Nutr; 2020 Feb; 8(2):1093-1103. PubMed ID: 32148818
[TBL] [Abstract][Full Text] [Related]
5. The Potential Anti-psoriatic Effects of Andrographolide: A Comparative Study to Topical Corticosteroids.
Dharmasamitha I; Mas Rusyati LM; Wati DK; Gelgel Wirasuta IMA
Recent Adv Inflamm Allergy Drug Discov; 2024 May; ():. PubMed ID: 38712377
[TBL] [Abstract][Full Text] [Related]
6. Suppressive effect of β, β-dimethylacryloyl alkannin on activated dendritic cells in an imiquimod-induced psoriasis mouse model.
Wang Y; Zhao J; Zhang L; Di T; Liu X; Lin Y; Zeng Z; Li P
Int J Clin Exp Pathol; 2015; 8(6):6665-73. PubMed ID: 26261548
[TBL] [Abstract][Full Text] [Related]
7. Vascular Endothelial Growth Factor A VEGFA Inhibition: An Effective Treatment Strategy for Psoriasis.
Chen Y; Tai Z; Zhu C; Yu Q; Zhu Q; Chen Z
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203230
[TBL] [Abstract][Full Text] [Related]
8. Emerging Treatments for Reactive Cutaneous Capillary Endothelial Proliferation.
Liu Y; Chen T; Zhang C; Pan W
Indian J Dermatol; 2023; 68(1):85-90. PubMed ID: 37151267
[TBL] [Abstract][Full Text] [Related]
9. Circadian rhythms in psoriasis and the potential of chronotherapy in psoriasis management.
Luengas-Martinez A; Paus R; Iqbal M; Bailey L; Ray DW; Young HS
Exp Dermatol; 2022 Nov; 31(11):1800-1809. PubMed ID: 35851722
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells.
Skolastika S; Hanif N; Ikawati M; Hermawan A
Evid Based Complement Alternat Med; 2022; 2022():4172531. PubMed ID: 35845599
[TBL] [Abstract][Full Text] [Related]
11. The application prospects of honokiol in dermatology.
Li Y; Liang C; Zhou X
Dermatol Ther; 2022 Aug; 35(8):e15658. PubMed ID: 35726011
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry.
Lin X; Meng X; Song Z; Lin J
Mol Cell Biochem; 2022 Jul; 477(7):1905-1920. PubMed ID: 35348980
[TBL] [Abstract][Full Text] [Related]
13. Antivascular endothelial growth factor-A therapy: a novel personalized treatment approach for psoriasis.
Luengas-Martinez A; Paus R; Young HS
Br J Dermatol; 2022 May; 186(5):782-791. PubMed ID: 34878645
[TBL] [Abstract][Full Text] [Related]
14. Magnolol may contribute to barrier function improvement on imiquimod-induced psoriasis-like dermatitis animal model via the downregulation of interleukin-23.
Guo JW; Cheng YP; Liu CY; Thong HY; Lo Y; Wu CY; Jee SH
Exp Ther Med; 2021 May; 21(5):448. PubMed ID: 33747183
[TBL] [Abstract][Full Text] [Related]
15. Honokiol: A Review of Its Anticancer Potential and Mechanisms.
Ong CP; Lee WL; Tang YQ; Yap WH
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877856
[TBL] [Abstract][Full Text] [Related]
16. Phyto-polyphenols as potential inhibitors of breast cancer metastasis.
Avtanski D; Poretsky L
Mol Med; 2018 Jun; 24(1):29. PubMed ID: 30134816
[TBL] [Abstract][Full Text] [Related]
17. Anti-psoriatic effects of Honokiol through the inhibition of NF-κB and VEGFR-2 in animal model of K14-VEGF transgenic mouse.
Wen J; Wang X; Pei H; Xie C; Qiu N; Li S; Wang W; Cheng X; Chen L
J Pharmacol Sci; 2015 Jul; 128(3):116-24. PubMed ID: 26220468
[TBL] [Abstract][Full Text] [Related]
18. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
